GENENTECH INC

DC

Pharmaceutical company

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 32 of its records are shown together here.

Filings
1,035
Filed By
32
Reported In-House
$121,259,095
Reported By Firms
$37,679,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2012 ALSTON & BIRD LLP 4th Quarter (Oct 1 - Dec 31)
AMENDED
$10,000
2012 JST STRATEGIES LLC (FORMERLY JOCHUM SHORE & TROSSEVIN PC) 4th Quarter (Oct 1 - Dec 31)
AMENDED
$20,000
2012 JEFFREY J. KIMBELL & ASSOCIATES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
—
2012 JEFFREY J. KIMBELL & ASSOCIATES, INC. 1st Quarter (Jan 1 - Mar 31)
AMENDED
$10,000
2012 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
2012 CM GOVERNMENT RELATIONS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$30,000
2012 CAUTHEN FORBES & WILLIAMS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report (No Activity)
$40,000
2012 THE FRANKLIN PARTNERSHIP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report (No Activity)
—
2012 ALSTON & BIRD LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$10,000
2012 THE MCMANUS GROUP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
Page 1 of 8  ·  74 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings